$10.58
-0.25-2.31%
Last update: Nov 10, 4:00 PM
Fennec Pharmaceuticals Inc
FENCNASDAQ
Fennec Pharmaceuticals rose 41.0% from $7.68 to $10.83, ahead of the S&P 500's +10.0%. Its worst day was Mar 24 (−19.2%), and its low came Mar 30 at $5.77.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.02 beat the $-0.05 estimate on $12.5M revenue (est. $11.2M).
+2.2% · S&P 500 0.0%
EPS of $-0.17 missed the $0.04 estimate on $13.8M revenue (est. $14.8M).
Story events cover the past 12 months · Times ET
−19.2%, the year's worst day · S&P 500 −0.3%
EPS of $0.01 beat the $-0.02 estimate on $15.1M revenue (est. $13.9M).
+36.5%, the year's best day, on 2M shares, the year's heaviest volume · S&P 500 +0.8%
EPS of $0.05 beat the $0.02 estimate on $17.9M revenue (est. $16.1M).
+16.8% · S&P 500 −0.3%
Where it ended: a close of $10.83 on Nov 9, 2026. Up next: Q3 2026 earnings on Nov 12, 2026 (EPS est. $0.10, revenue est. $18.9M).
Nothing in the past 12 months.
All FENC dividend historyReplay the year: the line draws itself and stops at each of the 4 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for FENC and SPY from Benzinga historical bars. Not investment advice.
